Glenmark Pharma receives USFDA approval for BenzaClin gel

Glenmark Pharmaceuticals has received final USFDA approval for its generic version of BenzaClin gel used in the treatment of acne. The ointment gel Clindamycin and Benzoyl Peroxide Gel, 1 per cent|5 per cent, is a generic version of BenzaClin1 Gel, 1 per cent/ 5 per cent, of Valeant Bermuda. According to market estimates, BenzaClin Gel, 1 per cent/ 5 per cent had sales of $99.4 million in the 12-month period ended January 2019.

Company Profile : Glenmark Pharma Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.